Statistical analysis
Data from all enrolled patients received at least 5 planned prime phase vaccinations were included in the safety and clinical outcome evaluation. Descriptive statistics were used to determine safety of neoantigen vaccine and changes in health-related quality of life. Bar chart of immune response and ctDNA dynamic curves were obtained using GraphPad Prism 8.